Dumaog, Leighton Jayce M.
HRN: 25-67-86 Sex: MalePatient Encounter
AMS Audit List
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
10/17/2024
AMPICILLIN 250MG (VIAL)
10/17/2024
10/23/2024
IV
110mg
Q12h
PSNB
Waiting Final Action
10/17/2024
AMIKACIN 250MG/ML, 2ML (VIAL/AMP)
10/17/2024
10/23/2024
IV
33mg
OD
PSNB
Waiting Final Action
10/19/2024
CEFOTAXIME 500MG (VIAL)
10/19/2024
10/25/2024
IVT
95mg
Q8
Sepsis
Waiting Final Action